LMD-06. A NSCLC patient with leptomeningeal metastasis harboring rare EGFR mutations G719S and L861Q benefited from doubling dosage of osimertinib: a case report

Leptomeningeal metastasis (LM) is a rare but lethal complication of advanced non-small cell lung cancer (NSCLC) that has a devastating impact on patient survival and quality of life. Osimertinib, an irreversible tyrosine kinase inhibitor, is approved as a therapy for advanced NSCLC with epidermal gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui, Shan, Changguo, Hong, Weiping, Wen, Lei, Lai, Mingyao, Cai, Linbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351183/
http://dx.doi.org/10.1093/noajnl/vdab071.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351183/
http://dx.doi.org/10.1093/noajnl/vdab071.031

Ejemplares similares